Related Experiment Video
Updated: May 4, 2026

Laparoscopic S7 Hepatectomy with Positive Fluorescence Staining
Published on: May 9, 2025
Imaging of the porta hepatis: spectrum of disease
Sree Harsha Tirumani1, Alampady Krishna Prasad Shanbhogue, Raghunandan Vikram
1From the Department of Imaging, Dana Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, Mass (S.H.T.); Department of Radiology, University of Texas Health Sciences Center at San Antonio, San Antonio, Tex (A.K.P.S.); Department of Radiology, University of Texas M.D. Anderson Cancer Center, Houston, Tex (R.V., S.R.P.); and Mallinckrodt Institute of Radiology, Washington University School of Medicine, St Louis, Mo (C.O.M.).
Insights
Pathologic conditions in the porta hepatis, including vascular and biliary diseases, require prompt diagnosis. Advanced imaging and interventions are crucial for managing these complex liver and transplant conditions.
Area of Science:
- Hepatobiliary and Transplant Surgery
- Diagnostic Imaging
- Gastroenterology
Background:
- The porta hepatis contains vital structures: portal vein, hepatic artery, bile ducts, lymphatics, nerves, and connective tissue.
- Pathologic conditions in this region range from vascular issues (thrombosis, stenosis, aneurysm) to biliary diseases (choledochal cysts, masses) and lymphadenopathy.
- The hepatoduodenal ligament, part of the porta hepatis, is a pathway for gastrointestinal and pancreatic cancer spread.
Purpose of the Study:
- To review the spectrum of pathologic conditions affecting the porta hepatis.
- To highlight the diagnostic role of imaging modalities in evaluating porta hepatis abnormalities.
- To discuss the management implications of these conditions, particularly in liver transplant recipients.
Main Methods:
- Review of common and uncommon diseases affecting the porta hepatis.
- Emphasis on the utility of ultrasonography, multidetector computed tomography (MDCT), and magnetic resonance imaging (MRI).
- Discussion of imaging-guided interventions such as embolization and stent placement.
Main Results:
- Vascular diseases like portal vein thrombosis and hepatic artery thrombosis/stenosis have significant therapeutic implications, especially in liver transplantation.
- Biliary diseases, including congenital choledochal cysts and acquired masses, present as lesions in the porta hepatis.
- Lymphadenopathy and rare neurogenic or connective tissue tumors can also occur; imaging is key for differentiation.
Conclusions:
- A comprehensive understanding of porta hepatis anatomy and pathology is essential for accurate diagnosis and management.
- Ultrasonography is the primary imaging modality for initial detection of vascular and biliary lesions.
- MDCT and MRI are vital for detailed characterization of masses, guiding treatment decisions and interventions.
Abstract:
A wide array of pathologic conditions can arise within the porta hepatis, which encompasses the portal triad (the main portal vein, common hepatic artery, and common bile ducts), lymphatics, nerves, and connective tissue. Major vascular diseases of the portal triad include thrombosis, stenosis, and aneurysm. Portal vein thrombosis can complicate liver cirrhosis and hepatocellular carcinoma and has important therapeutic implications. Hepatic artery thrombosis and stenosis require immediate attention to reduce graft loss in liver transplant recipients. Congenital (eg, choledochal cyst) and acquired (benign and malignant) diseases of the biliary system can manifest as mass lesions in the porta hepatis. Lymphadenopathy can arise from neoplastic and nonneoplastic entities. Uncommon causes of mass lesions arise from nerves (eg, neurofibroma, neurofibrosarcoma) and connective tissue (sarcomas) and are rare. The hepatoduodenal ligament is a peritoneal reflection at the porta hepatis and is an important route for the spread of pancreatic and gastrointestinal cancers. Imaging plays a major role in diagnosis and enables appropriate management. Ultrasonography accurately demonstrates anatomic variations and pathologic conditions and is the initial modality of choice for detection of vascular and biliary lesions. Multidetector computed tomography and magnetic resonance imaging allow characterization and differentiation of various masses in the porta hepatis. Imaging-guided interventions, including embolization and stent placement, also play a key role in disease management.
Related Concept Videos
Portal Hypertension
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Hepatic Portal System
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
Liver Histology
Hepatocytes perform a variety of essential functions. They secrete...
Hepatic Encephalopathy

